Background and objectives
French pharmaceutical group present in over 100 countries
As part of the ESEF requirements for electronic financial statements, the Group needed support in tagging its primary statements.
Our mission
A two-year support program
In the first year, we assisted the Group in tagging all its IFRS financial statements; for this new exercise, it was necessary to train the in-house team so that it could familiarize itself with the new regulations and the minimum rules required to assume responsibility for the work.
In the second year, we had to update the first year’s markup, to incorporate both the Group’s own developments and changes in the Taxonomy and market practices. We also assisted the Group in its dealings with the statutory auditors
We also took charge of setting up the Disclosure Management tool and analyzing technical controls.
Results
The mapping of the primary financial statements was completed on schedule and approved by the statutory auditors.
Data entry into the DM tool was also completed on time, and the technical controls were cleared.
